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High resolution peripheral quantitative computed tomography (HR-pQCT) is a
3-dimensional imaging modality with superior sensitivity for bone changes and
abnormalities. Recent advances have led to increased use of HR-pQCT in inflammatory
arthritis to report quantitative volumetric measures of bone density, microstructure,
local anabolic (e.g., osteophytes, enthesiophytes) and catabolic (e.g., erosions) bone
changes and joint space width. These features may be useful for monitoring disease
progression, response to therapy, and are responsive to differentiating between
those with inflammatory arthritis conditions and healthy controls. We reviewed 69
publications utilizing HR-pQCT imaging of the metacarpophalangeal (MCP) and/or wrist
joints to investigate arthritis conditions. Erosions are a marker of early inflammatory
arthritis progression, and recent work has focused on improvement and application
of techniques to sensitively identify erosions, as well as quantifying erosion volume
changes longitudinally using manual, semi-automated and automated methods. As a
research tool, HR-pQCT may be used to detect treatment effects through changes in
erosion volume in as little as 3 months. Studies with 1-year follow-up have demonstrated
progression or repair of erosions depending on the treatment strategy applied. HR-pQCT
presents several advantages. Combined with advances in image processing and image
registration, individual changes can be monitored with high sensitivity and reliability. Thus,
a major strength of HR-pQCT is its applicability in instances where subtle changes are
anticipated, such as early erosive progression in the presence of subclinical inflammation.
HR-pQCT imaging results could ultimately impact decision making to uptake aggressive
treatment strategies and prevent progression of joint damage. There are several potential
areas where HR-pQCT evaluation of inflammatory arthritis still requires development. As a
highly sensitive imaging technique, one of themajor challenges has beenmotion artifacts;
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motion compensation algorithms should be implemented for HR-pQCT. New research
developments will improve the current disadvantages including, wider availability of
scanners, the field of view, as well as the versatility for measuring tissues other than
only bone. The challenge remains to disseminate these analysis approaches for broader
clinical use and in research.
Keywords: HR-pQCT (high-resolution peripheral quantitative computed tomography), arthritis, joint space,
erosions, osteophytes, bone mineral density, bone microstructure
INTRODUCTION
Imaging is playing an increasing role in the diagnosis and
monitoring of inflammatory disease. For many years the only
imaging modality for joint assessment was conventional
radiographs (CR); however, newer technologies have
revolutionized the diversity of medical imaging capabilities
in rheumatic diseases. Magnetic resonance imaging (MRI) and
ultrasound (US) are now used regularly in both research and
clinical practice for investigating joint diseases, particularly for
the identification of soft tissue pathology and inflammation.
In contrast, computed tomography (CT) capitalizes on the
ability of bone to attenuate x-rays, thus providing excellent
bone contrast in three dimensions with high spatial resolution
but is limited by poor soft-tissue contrast. High-resolution
peripheral quantitative computed tomography (HR-pQCT)
imaging was designed to examine volumetric bone mineral
density and microstructure of the radius and tibia and has been
used extensively in osteoporosis research. HR-pQCT uses the
same principles as traditional CT but can achieve a much higher
spatial resolution and still has a very low radiation dose. The
total effective dose for the metacarpophalangeal (MCP) joint and
wrist scans is ∼0.025 mSv (1). For comparison, the radiation
dose for a conventional chest X-ray is 0.1 mSv. Still, HR-pQCT
has a smaller field of view. Isotropic voxel sizes of 61 or 82µm
lead to spatial resolutions of 100 or 142µm, respectively,
approximately the thickness of an individual human trabecula.
The high resolution allows segmentation of the bone at the
microstructural level, permitting quantification of architecture
and micro-scale pathological features, such as erosions. Initially
limited by a gantry size that limited imaging to distal joints in
the hands (Figure 1), wrist, foot, and ankles only, the newest
generation HR-pQCT permits more proximal imaging of the
elbows and knee, expanding capabilities to important anatomic
sites in the context of inflammatory arthritis.
In 2011 the Study grouP for x-trEme Computed Tomography
in Rheumatoid Arthritis (SPECTRA) was formed to facilitate
the worldwide collaboration of periarticular image acquisition
standards, image interpretation and analysis guides, and
applications in clinical research. A systematic review was
published in 2016, detailing the published research of HR-
pQCT imaging and arthritis (2). Since then, the number
of published papers has more than doubled, suggesting the
importance of this review to update the current knowledge
and expanded uses of this technology. We have structured
this review to summarize pathological findings observed at the
metacarpophalangeal (MCP) and wrist joints in different types
FIGURE 1 | Example demonstrating how a participant is positioned for
XtremeCTII scanning. (A) Participant’s hand is positioned on a rigid-formed
mold, with straps securing the distal and proximal ends of the forearm. An
additional x-ray compatible, inflatable, pad-based positioning system (red
arrows) is positioned above the hand to further reduce accidental motion
during scan acquisitions. (B) The secured appendage is then placed within a
cylindrical, annular, carbon-fiber molded sample holder. Using three spherical
landmarks (black arrows), and with the participant resting comfortably, the
supported participants’ hand and sample holder is then securely and
accurately placed within the scanner (C).
of peripheral inflammatory arthritis using HR-pQCT, compare
HR-pQCT imaging outcomes with other modalities in terms of
erosions, joint space width, bony proliferations, bone density and
microstructure, summarize the reproducibility of the quantitative
outcome measures assessed with HR-pQCT imaging, investigate
early detection of arthritis, the longitudinal changes over time
for the quantitative outcome measures, and finally discuss the
implications of the use of HR-pQCT in inflammatory arthritis
and future directions.
MATERIALS AND METHODS
Search Strategy
US National Library of Medicine Medical Subject Heading
(MeSH) terms, keywords, and acronyms for HR-pQCT were
selected. We combined this search with MeSH terms, keywords,
and acronyms for the metacarpophalangeal joints (MCP) and/or
radius and/or wrist, to specify the periarticular regions of interest,
and MeSH terms and keywords for arthritis (search terms
available in Appendix 1 in Supplementary Material). PubMed
(1966–January 2020) and Embase (1980–January 2020) searches
were conducted to identify potentially relevant studies. Filters
were applied to eliminate animal studies and identify English
language studies and full-length articles.Web of Science was used
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to identify articles which referenced the articles found through
PubMed and Embase. References from identified articles were
checked manually. Authors from the SPECTRA Collaboration
aided in identifying any potential studies we did not find through
the other searches.
Inclusion Criteria
Any studies reporting original results of HR-pQCT imaging
of the MCP and/or wrist joints were selected through
the title/abstract search. These studies could report on the
normal state or any arthritis conditions [including RA,
osteoarthritis (OA), PsA], as well as “pre-arthritis” states
[e.g., persons positive for anticitrullinated protein antibodies
(ACPA) with arthralgia]. At the full-text review stage, we
selected articles for data extraction if they reported on any
of the following outcomes: (1) pathology findings, determined
a priori to include bone mineral architecture, bone mineral
density (BMD), erosions, vascular channels, cortical breaks,
joint space, bony proliferations, or surface changes; (2)
comparison to other imaging modalities; and (3) reproducibility.
Article selection and data extraction were performed by one
author (RKJ).
FIGURE 2 | Flow diagram for study inclusion. DXA, Dual x-ray absorptiometry; HR-pQCT, High-resolution peripheral quantitative computed tomography; OP,
Osteoporosis; SjS, Sjogren’s syndrome; SpA, Spondyloarthritis; SLE, Systemic lupus erythematosus; microCT, Micro-computed tomography.
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Analysis
Owing to the heterogeneity of case definitions for different
pathologies, variations in analysis techniques, and the
identification of studies in a variety of normal and disease
states, it was not possible to perform a meta-analysis. Therefore,
a narrative summary of the work was performed following
pathology descriptions and comparisons to other imaging
modalities and reproducibility.
PATHOLOGY
A total of 291 unique publications were identified, each subject
to selection based on the title and abstract. One hundred and
three met eligibility for full-text review, with 69 selected for
data extraction (Figure 2). Of these 69 articles, 66 described
pathology findings, 28 related comparisons of HR-pQCT findings
to another imaging modality, and 35 described precision or
reproducibility. All the studies meeting inclusion criteria are
detailed in Table 1.
Erosion Detection by HR-pQCT
Bone erosions were originally defined radiographically as breaks
in the cortical bone surface, typically accompanied by loss of
underlying trabecular bone (71–73).
Erosions onHR-pQCT have been defined in a diverse manner;
the early studies simply defined erosion as a clear juxta-articular
break of the cortical shell (4, 5) while others stated that the break
had to be seen in a minimum number of consecutive slices (3).
Not until 2016 was a clear definition proposed by the SPECTRA
Collaboration following a consensus exercise (63). Erosions were
defined as (1) a definite break in the cortical bone; (2) the cortical
break must extend over at least two consecutive slices; (3) the
cortical break must be detectable in two perpendicular planes; (4)
the cortical interruptionmust have a loss of underlying trabecular
bone, and (5) the cortical interruption must be non-linear in
shape to differentiate from vascular channels penetrating the
cortices (Figure 3). In contrast, cortical breaks or interruptions
have been defined as a clear interruption of the cortex, seen on
two consecutive slices on two orthogonal planes but without the
need to demonstrate loss of trabecular bone or shape (34). Such,
cortical breaks or interruptions have not been incorporated in the
SPECTRA definition of erosions.
The high spatial resolution of HR-pQCT images has allowed
deeper investigation into the role of these erosions in the
inflammatory arthritis disease course. Forty-six publications
characterizing erosions or cortical breaks/interruptions were
found. Erosions have been assessed in a variety of arthritic
conditions including early inflammatory arthritis (3, 33, 37, 53,
58, 59, 67), RA (1, 3–7, 9, 10, 12, 15, 23, 26, 28–30, 34, 39, 40, 44,
46–48, 52, 54, 55, 61, 64, 65, 67), PsA (5, 7, 14, 49, 61, 66, 69), and
erosive hand OA (21), as well as healthy controls (3, 5, 7, 16, 33,
39, 40, 44, 45, 52, 54, 55, 60, 61, 64, 67) and subjects with ACPA
antibodies but no features of arthritis (32, 50, 62).
Erosions are most abundant in patients with RA (3, 4, 16,
33, 52, 54, 55, 57, 64, 65, 69), especially ACPA and rheumatoid
factor (RF) positive RA patients (26). The erosions exhibit a clear
predilection for the radial and ulnar quadrant of the 2nd and 3rd
MCP joints. Erosions are most common in the metacarpal head
but are also prevalent in the proximal interphalangeal (PIP) bases
(4, 15). Although patients with PsA also exhibited a high degree of
erosive damage (69), erosions are not as prevalent in PsA patients
when compared with RA patients (5, 7, 61). For patients with
PsA, erosions are most common in the radial quadrant. However,
PsA erosions were also found to a high degree in the dorsal
and palmar quadrant of the MCP joint (5, 69). Differences in
erosion morphology have also been described in RA compared
with PsA patients. In one study, erosions in RA patients were
typically U-shaped in appearance, while erosions in PsA patients
are more often tubule and -shaped (5); these findings have not
been confirmed in other studies. The possible differences in shape
may reflect different pathophysiological mechanisms, leading to
greater erosion repair in PsA than RA, or alternatively, these
morphological phenotypes may reflect differences in disease
severity. Further investigation is needed to explore differences
between morphologies observed in RA and PsA.
Typically, erosion presence has been assessed manually by
an experienced reader. However, manual scoring is laborious
and requires substantial training and standardization. An
automated detection algorithm has been developed, named
the Cortical Interruption Detection Algorithm (39, 40, 52, 53,
64). The Cortical Interruption Detection Algorithm detects the
presence of cortical interruptions, directing the reader to lesion
locations to verify that they meet the erosion definition as
opposed to those that merely represent physiological breaks
in the cortical bone, i.e., vascular channels (Figure 4A) or
stack misalignment (Figure 4B) and osteophyte formation
(Figure 4C). This algorithm also captures very small cortical
breaks (>0.246mm in diameter) that can be challenging to detect
through visual inspection (39, 40).
Comparison of Erosion Detection With
Other Imaging Modalities
Erosion detection by HR-pQCT has been compared with other
pre-clinical and clinical imaging modalities. An image review
showing erosions on HR-pQCT, MRI, and CR have also been
published for patients with RA (33).
Micro-computed tomography (microCT) applies the same
technology as HR-pQCT for pre-clinical investigations but uses
a smaller field of view to acquire even higher spatial resolution
images (<10µm, depending on the size of the sample and
scanner characteristics) that can be performed on ex vivo samples
only. Two studies compared cortical interruption detection using
HR-pQCT with microCT as a gold standard. The sensitivity
of HR-pQCT in detecting cortical interruptions was 82% (34).
MicroCT has also been used as a gold standard in order to
investigate the ability of the Cortical Interruption Detection
Algorithm to find the minimum diameter to detect and quantify
cortical interruptions on HR-pQCT. This algorithm performed
best for the detection of cortical interruptions with a minimum
diameter of 0.16 mm (40).
Additional research has been performed comparing clinical
CR and MRI with HR-pQCT, as a gold standard, for the
detection of erosions (Figure 5). In a clinical setting, CR is still
the gold standard. The sensitivity of erosion detection by CR
was 61 to 68% when HR-pQCT was considered as a reference
(1, 12). Face validity of HR-pQCT identification of erosions
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TABLE 1 | Studies included in the systematic review.
Author, year (ref) Participants Type of study Joints included Outcomes Other
modalities
Fouque-Aubert, 2010 (3) RA (n = 57); eRA (n = 36); control (n
= 43)
Cross-sectional MCP Erosions, BMD,
microstructure
Stach, 2010 (4) RA (n = 58); control (n = 30) Cross-sectional MCP; Radius Erosions, Osteophyte
Finzel, 2011 (5) RA (n = 58); PsA (n = 30) Cross-sectional MCP Erosions, Osteophyte
Finzel, 2011 (6) RA (n = 30) Cohort MCP Erosions
Finzel, 2011 (7) RA (n = 14); PsA (n = 6); control (n =
6)
Cross-sectional MCP Erosions US
Zhu, 2012 (8) RA (n = 100) Cross-sectional MCP; Radius BMD, microstructure DXA
Albrech, 2013 (9) RA (n = 50) Cross-sectional MCP Erosions MRI
Aschenberg, 2013 (10) RA (n = 40) Cohort MCP Erosions, Osteophyte
Barnabe, 2013 (11) eRA (n = 10) Cross-sectional MCP JSW
Barnabe, 2013 (12) RA (n = 15); control (n = 15) Cross-sectional MCP; PIP Erosions, JSW, BMD,
microstructure
CR
Burghardt, 2013 (13) RA (n = 16); control (n = 7) Cross-sectional MCP; Radius JSW CR
Finzel, 2013 (14) PsA [(n = 41) TNFi/MTX n = 28/13] Cohort MCP Erosions, Osteophyte
Finzel, 2013 (15) RA (n = 20) Cohort MCP Erosions
Srikhum, 2013 (16) RA (n = 16); control (n = 7) Cross-sectional MCP; Radius Erosions MRI
Zhu, 2013 (17) RA (n = 66); control (n = 66) Cross-sectional Radius BMD, microstructure DXA
Kleyer, 2014 (18) ACPA+ (n = 15); ACPA– (n = 15) Cross-sectional MCP BMD, microstructure
Kocijan, 2014 (19) RA (n = 90); control (n = 70) Cross-sectional Radius BMD, microstructure
Kocijan, 2014 (20) RA (n = 60); PsA (n = 50) Cross-sectional Radius BMD, microstructure
Finzel, 2014 (21) PsA (n = 25); HOA (n = 25); control
(n = 20)
Cross-sectional MCP Osteophyte
Teruel, 2014 (22) RA (n = 16) Cross-sectional Radius BMD, microstructure MRI
Töpfer, 2014 (23) RA (n = 18) Cross-sectional MCP Erosions
Zhu, 2014 (24) RA (n = 50); control (n = 50) Cross-sectional Radius BMD, microstructure
Zhu, 2015 (25) PsA (n = 53); control (n = 53) Cross-sectional Radius BMD, microstructure DXA
Hecht, 2015 (26) RA (n = 242) Cross-sectional MCP Erosions
Kocijan, 2015 (27) PsA (n = 50); PsO (n = 30); control (n
= 70)
Cross-sectional Radius BMD, microstructure
Lee, 2015 (1) RA (n = 16) Cross-sectional MCP; Radius Erosions MRI; CR
Regensburger, 2015 (28) RA (n = 103) Cross-sectional MCP; Radius Erosions MRI
Töpfer, 2015 (29) RA (n = 22) Cohort MCP Erosions, BMD
Barnabe, 2016 (30) Cross-sectional MCP Erosions
Figueriredo, 2016 (31) ACPA+ RA (n = 202) Cohort MCP Erosions, Osteophytes
Kleyer, 2016 (32) ACPA+ (n = 20); ACPA– (n = 13) Cross-sectional MCP Erosions MRI
Scharmga, 2016 (33) RA (n = 34); eRA (n = 10); control (n
= 38)
Cross-sectional MCP Erosions MRI; CR
Scharmga, 2016 (34) Cadaver (n = 10) Cross-sectional MCP; PIP Erosions µCT
Shen, 2016 (35) PsA (n = 80) Cross-sectional Radius BMD, BMS DXA
Tom, 2016 (36) Cadaver (n = 7) Cross-sectional MCP JSW
Feehan, 2017 (37) eRA (n = 30); control (n = 30) Cohort MCP; Radius BMD, BMS
Kleyer, 2017 (38) RA (n = 15); PsA (n = 15); control (n
= 15)
Cross-sectional MCP 3D printing
Peters, 2017 (39) RA (n = 7); control (n = 3) Cross-sectional MCP Erosions
Peters, 2017 (40) RA (n = 32); control (n = 32) Cohort MCP Erosions µCT
Scharmga, 2017 (41) Cadaver (n = 7) Cross-sectional MCP Erosions, VC
Shimizu, 2017 (42) RA [(n = 27) TNFi/MTX n = 17/10] Cohort MCP; Radius Erosions, JSW, BMD MRI; CR
Simon, 2017 (43) RA (n = 106); control (n = 108);
Cadaver (n = 6)
Cross-sectional MCP; Radius BMD, BMS
Werner, 2017 (44) RA (n = 107); control (n = 105);
Cadaver (n = 6)
Cross-sectional MCP; Radius Erosions, VC µCT
(Continued)
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TABLE 1 | Continued
Author, year (ref) Participants Type of study Joints included Outcomes Other
modalities
Yang, 2017 (45) RA (n = 12); control (n = 20) Cross-sectional MCP; Radius BMD, microstructure
Yue, 2017 (46) RA (n = 20); RA (n = 20) Cohort MCP Erosions
Figueriredo, 2018 (47) RA (n = 65) Cross-sectional MCP Erosions
Ibrahim-Nasser, 2018 (48) RA (n = 29) Cross-sectional MCP Erosions, BMD,
microstructure
CR
Kampylafka, 2018 (49) PsA [(n = 20) IL17 = 20) Cohort MCP; PIP; Radius Erosions, Osteophytes,
BMD,
microstructure
MRI; US
Keller, 2017 (50) Control [ACPA+ (n = 29); ACPA– (n
= 29)]
Cross-sectional MCP Erosions, BMD,
microstructure
Kong, 2018 (51) RA [(n = 32) US+/– n = 20/12] Cross-sectional MCP BMD, microstructure US
Peters, 2018 (52) RA (n = 41); control (n = 38) Cross-sectional MCP; PIP Erosions MRI; CR
Peters, 2018 (53) eRA (n = 17); undifferentiated arthritis
(n = 4)
Cross-sectional MCP Erosions
Scharmga, 2018 (54) RA (n = 39); control (n = 38) Cross-sectional MCP; PIP Erosions MRI; CR
Scharmga, 2018 (55) RA (n = 20); control (n = 10) Cross-sectional MCP; PIP Erosions CR
Simon, 2018 (56) RA ACPA + (n = 106); RA ACPA – (n
= 30); CD (n = 43); UC (n = 27); PsO
(n = 74); PsA (n = 88); control (n
= 108)
Cross-sectional MCP BMD, microstructure
Simon, 2018 (57) PsA (n = 55); PsO (n = 55); control (n
= 47)
Cross-sectional MCP Erosions, Osteophytes
Yue, 2018 (58) eRA (n = 63); Remission/not
remission
Cohort MCP Erosions, BMD,
microstructure
Finzel, 2019 (59) eRA (n = 66 TOC/TNFi n = 33/33) Cohort MCP; Radius Erosions
Berlin, 2019 (60) Control (n = 120) Cross-sectional MCP; PIP Erosions, Osteophytes
Henchie, 2019 (61) RA (n = 17); PsA (n = 17); control (n
= 12)
Cross-sectional MCP Erosions, Osteophytes
Keller, 2019 (62) Control [ACPA+ (n = 22); ACPA– (n
= 23)]
Cohort MCP; Radius Erosions
Manske, 2019 (63) RA (n = 43) Cross-sectional MCP JSW CR
Peters, 2019 (64) RA (n = 32); control (n = 32) Cohort MCP; PIP Erosions, BMD,
microstructure
CR
Shimizu, 2019 (65) RA [(n = 28) TNFi+/– n = 18/10] Cohort Radius Erosions MRI
Wu, 2019 (66) PsA (n = 60) Cohort MCP Erosions, Osteophytes.
Yue, 2019 (67) eRA (n = 117) Cohort MCP Erosions
Simon, 2019 (68) PsA [(n = 165) None/MTX/bDMARD
n = 79;52;34]
Cross-sectional Radius BMD, microstructure
Wu, 2020 (69) PsA (n = 62); control (n = 62) Cross-sectional MCP Erosions, Osteophytes,
BMD, microstructure
Stok, 2020 (70) RA (n = 30) Cross-Sectional MCP JSW
RA, Rheumatoid arthritis; PsA, Psoriasis arthritis; PSO, Psoriasis; ACPA, Anticitrullinated protein antibodies; US, Ultrasound; IL, interleukin; TNFi, Tumor necrosis factor inhibitors;
TOC, tocilizumab; UC, Ulcerative colitis; CD, Crohn’s disease; MTX, Methotrexate; bDMARD, biological Disease-modifying antirheumatic drug; BMD, Bone mineral density; MCP,
Metacarpophalangeal; PIP, proximal interphalangeal.
was supported by one study that reported that the Sharp/van
der Heijde (SvH) score based on MCP and PIP joints using
CR were significantly associated with the number and size of
erosions by HR-pQCT (52). However, the HR-pQCT scanner has
a much smaller field of view, and it remains unknown if the
added benefit of the greater sensitivity can make up for the fewer
joints examined.
Twelve studies have compared erosion detection by HR-
pQCT and MRI, with HR-pQCT as the gold standard,
in patients with RA, PsA as well as ACPA positive
arthralgia patients without arthritis. The sensitivity for MRI
erosion detection ranged from 60 to 86% (1, 9, 16, 28),
while the specificity was 97 to 100% (1, 9, 28, 32). HR-
pQCT was superior at detecting erosions of less than 10
mm3 (9).
HR-pQCT has also been used as a reference for erosion
detection in order to compare it with US (7). US and HR-
pQCT were consistent in the measurement of the width of
erosions. However, there was a 10% false-negative rate, and 29%
false-positive rate for erosion detection by US. False-negative
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FIGURE 3 | Example of a cortical break meeting the SPECTRA definition of erosion by high-resolution peripheral quantitative computed tomography imaging in the
radial quadrant of the second metacarpophalangeal joint from a 54-year-old female patient with rheumatoid arthritis. Arrows indicate the cortical break. (A,B) Are the
grayscale, consecutive slices. (C) Is the 3D segmentation, performed using thresholding (3D Slicer, http://www.slicer.org). Images provided courtesy of Aarhus
University (RKJ, KKK, EMH).
results recorded with US were due to its limited resolution to
detect cortical lesions <2mm in width. It was interpreted that
the false-positive results occurred because of surface irregularities
suggestive of bone erosions on US (7). US has a crucial
drawback, as some quadrants of the joints are hard to visualize
due to the acoustic window, e.g., radial or ulnar quadrant of
the 3rd MCP.
Overall, these findings indicate that HR-pQCT detects
more erosions and cortical interruptions than any other
clinical imaging modality. However, with increased spatial
resolution, more cortical interruptions are observed; this
likely includes more physiological cortical interruptions,
i.e., vascular channels. However, the higher resolution
could also help distinguish pathological from physiological
cortical interruptions.
Quantitative Evaluation of Erosions From
HR-pQCT Imaging
As a result of the high spatial resolution and 3D imaging, accurate
quantification of erosion size is possible. Several published
methods exist, including semiquantitative scores (1, 4, 16),
manual measures of the maximal dimension of width and
depth (5, 7, 15, 30, 46, 48, 58), sphericity (23, 29), and surface
area (23, 52, 64). Erosion volume is the most commonly used
method due to the ability to detect changes (progression or
repair) in three dimensions. However, there is presently no
consensus on how to quantify erosion volume. Erosion width
and depth have been manually assessed using OsiriX medical
imaging software (Pixmeo, Bernex, Switzerland) (48, 50, 62,
65). The erosion volume can then be estimated from a half-
ellipsoid formula (9, 23, 26, 28, 47, 57) or ellipsoid formula
(Figure 6A) (42). More recently, semi-automated and automated
algorithms have been introduced. These include Medical Image
Analysis Framework (MIAF) (custom software developed at
the University of Erlangen; Figure 6B) (23, 29), modified
Evaluation Script for Erosions (mESE; using Image Processing
Language, Scanco Medical) (47), Cortical Interruption Detection
Algorithm (custom analysis developed at Maastricht University
and EindhovenUniversity of Technology using Image Processing
Language, Scanco Medical; Figure 7) (39, 40, 52, 53, 64) and a
surface transformation algorithm (custom software developed at
Worcester Polytechnic Institute; Figure 8) (61). MIAF, mESE,
and the Cortical Interruption Detection Algorithm perform a
segmentation of the bone and an estimation of the location
of the cortical break. Based on this segmentation, the number
of voxels in the erosion are counted, producing a true
volumetric measure of erosion size. In contrast, the surface
transformation algorithm uses statistical shape modeling to
compare surface deformities of inflammatory arthritis joints
with healthy joints, producing measurements of erosion depth
(Figure 8) (61).
A single study compared erosion volumes measured
manually (estimated from width and depth and calculated
assuming the erosion approximated a half-ellipsoid) and
using MIAF and mESE. While erosion volumes were similar
when measured with the semi-automated methods, manual
measurements yield significantly lower absolute volume
measures compared with semi-automated methods, particularly
for irregularly shaped erosions, illustrating that the erosions
should not be assumed to be shaped like a half-ellipsoid
(47). To date, no other studies have compared other erosion
measurement algorithms.
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FIGURE 4 | HR-pQCT images of cortical breaks, which do not meet the SPECTRA definition for erosions. Arrows indicate the cortical break. Patient A, where (A1,A2)
are consecutive slices and (A3) is the 3D segmentation. Third MCP Joint from a 67-year-old male patient with rheumatoid arthritis. The cortical break is linear in
shape. Therefore, the cortical break is defined as a vascular channel Patient B, where (B1,B2) are consecutive slices, and (B3) is the 3D segmentation. Second MCP
Joint from a 51-year-old female patient with rheumatoid arthritis. Cortical break in relation to stack misalignment represented by *. Patient C, where (C1,C2) are
consecutive slices and (C3) are 3D segmentation. Second MCP Joint from a 51-year-old female patient with rheumatoid arthritis. Cortical break in relation to a bony
proliferation. Images provided courtesy of Aarhus University (RK-J, KK, and E-MH).
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FIGURE 5 | Conventional Radiography (A,B) and HR-pQCT imaging (C–E) from a 62-year-old male patient with rheumatoid arthritis. Anterior-posterior view of the
right hand (A). Enlargement of the second metacarpophalangeal joint (B). High-resolution peripheral quantitative computed tomography images of the second MCP
joint as 3D segmentations performed using thresholding (C) (3D Slicer, http://www.slicer.org) and the axial (D), coronal (E), and sagittal (F) plane, congruent with the
corresponding radiograph. The arrow demonstrates the erosion location. Images provided courtesy of Aarhus University (RKJ, KKK, EMH).
Vascular Channels and Cortical
Micro-Channels
The high resolution of HR-pQCT not only reveals cortical
interruptions meet the definition of erosions but also
interruptions which have been hypothesized to be vascular
channels. According to the SPECTRA erosion definition, the
cortical interruption was suspected to be vascular channels if the
interruption was characterized by a parallel cortical lining seen
on two consecutive slices and two orthogonal planes (41).
Efforts have been made to test this hypothesis. One study
investigated 10 cadaveric fingers, not necessarily affected by
inflammatory arthritis, imaged by HR-pQCT with subsequent
histological evaluation. Fifty-two vascular channels were
identified by histology, and 11 of these fulfilled the definition
of erosions on HR-pQCT. Seven cortical breaks which fulfilled
the SPECTRA definition of vascular channels were located. Five
could be evaluated with histology, and only one of these was
a true vascular channel. While they are not vascular channels,
these microchannels may provide a link between the synovium
and the bone marrow (41). Another approach for investigating
vascular channels was to inject the contrast agent Imeron into the
ulnar and radial artery of six cadaveric hands prior to HR-pQCT
scanning (44). This technique detected very small intraarticular
vascular channels. The vascular channels, however, were located
proximal to the cortical micro-channels. With both studies, it
is possible that very small vascular channels escaped detection
due to the challenges of visualizing by perfusion and casting,
microCT contrast or standard histological stains (44).
These findings do support the suggestion that bone has a
large number of channels passing from the inside to the outside
of the bone that is not necessarily linked to erosions, nor do
all channels contain vessels. The shape of cortical interruptions
cannot be used to accurately decide if cortical breaks contain
vessels, as many cortical interruptions, that do not have a classic
linear shape, contain vessels (41). Understanding the role of
these various channels may be important to understand RA
pathology. Traditionally, it has been postulated that synovitis is
an initial process that is succeeded by bone involvement known
as the “outside-in hypothesis.” Conversely, it has been suggested
that RA is primarily a bone marrow disease which subsequently
affects the synovial membrane; this is known as the “inside-
out hypothesis” (74). The cortical micro-channels connect the
synovial compartment with the bone marrow and might be
important in investigating whether bone damage begins from
the inside-out or outside-in (75, 76). HR-pQCT will be useful in
combination with other imaging techniques to understand some
of these pathological mechanisms.
Bony Proliferations
Bony proliferation is another common pathologic feature of
many arthritic diseases, including PsA, primary hand OA and
secondary OA due to inflammatory arthritis. There is currently
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FIGURE 6 | (A) Manual measurement of erosion width and depth.
(B) Semi-automated erosion volume assessment using MIAF (University of
Erlangen). Images provided courtesy of the University of Calgary (JJT, CB,
SLM).
no consensus on how to define or quantify the assessment of bony
proliferations. However, most studies have defined osteophytes
and enthesophytes in a similar fashion; these include bony
protrusions from the juxta-articular cortical shell (4, 5, 10, 14,
21, 57) (Figure 9), bony proliferation at specific anatomical
sites (57), or bone formation arising from the periosteal bone
cortex at the insertion sites of the capsule, ligament, or tendons
(66, 69). Thirteen publications characterizing osteophytes or
enthesophytes with HR-pQCT were found; 8 of which were
cross-sectional studies. In three of the studies, the osteophytes
or enthesophytes were graded on a semi-quantitative scale (0–
3) according to the height measured as the maximum distance
between the original and the new cortical lining (4, 5, 21). Two
of these three studies also presented direct measurements of
the height. The remaining five studies measured osteophyte or
enthesophyte height directly (5, 14, 21, 57), and one of these also
segmented the osteophyte volume (69). Two studies found that
chronic RA patients had a greater number and larger osteophytes
than healthy subjects (4, 61); these osteophytes were found
mostly in the palmar and dorsal quadrant of the joints. PsA
patients had a greater number and size of osteophytes relative to
RA patients (5, 61). The highest number of osteophytes in PsA
patients was observed in the radial quadrant, closely followed by
the dorsal and palmar quadrants. Enthesophytes in patients with
PsA is more abundant and greater in size compared to healthy
subjects. The majority of enthesophytes in patients with PsA
were found at the palmar and dorsal quadrants of the metacarpal
heads (57). The volume of enthesophytes is also significantly
greater in patients with PsA compared to healthy controls (69).
Patients with PsA had a similar number and size of osteophytes
compared to those with hand OA. The osteophytes of patients
with hand OA were seen predominantly in the palmar and dorsal
quadrant, while the distribution of osteophytes in patients with
PsA was more widespread (21). In addition, patients with PsA
have significantly taller and more abundant bony proliferations
(5). There have also been attempts to study bony proliferations
according to age. In healthy subjects, the number of osteophytes
in the 2nd and 3rd MCP and PIP joints were found to increase
with age (60). The number and height of enthesophytes also
increase with age; these have been observed not only in patients
with PsA but also in healthy subjects. Therefore, the progression
of osteophytes may not solely signify disease severity but may
also indicate normal age-related change (57). Like erosions,
the sensitivity for enthesophyte detection by HR-pQCT is far
higher than MRI as 89% of PsA patients had enthesophytes by
HR-pQCT, while they were observed in only 30% of the PsA
patients on MRI (49). Presently, it is unknown whether there is
a benefit of HR-pQCT imaging for tracking the progression of
bony proliferation compared to conventional radiographs since
no studies have compared the sensitivity and osteophytes seem
to progress despite therapy.
Joint Space Width
HR-pQCT images can also be used to quantify joint space width
and volume based on the 3D volume between the bones rather
than the 2D analysis that is typically applied to conventional
radiographs. Seven publications with joint space analysis were
found; all but one has investigated the validity of proposed semi-
automatic scripts. Three different algorithms were developed
using a similar methodology (11, 13). A consensus method
has recently been published by the SPECTRA Collaboration
(Figure 10), this method is proposed for universal use in
ongoing and future clinical trials of arthritic conditions (70).
The established joint space width (JSW) metrics include mean,
minimum and maximum JSW as well as standard deviation,
asymmetry (maximum/minimum) and joint space volume. A
single study has investigated the validity of a JSW script on
cadaveric MCP joints at different flexion angles. The study found
in order to have reliable joint space measures, the acquisition of
the joints had to be < 10 degrees flexion for longitudinal studies
(36). Whether the joint space analysis is affected by other factors
such as joint swelling, is currently under investigation.
Lastly, two studies evaluated relationships between joint space
narrowing assessed from CR and 3D joint space analysis on
HR-pQCT. Minimum JSW, JSW standard deviation, and JSW
asymmetry assessed by HR-pQCT were associated with SvH joint
space score (13, 63).
The minimum joint space width has been shown to be
significantly smaller in patients with RA compared to healthy
subjects, which is suggestive of a loss of cartilage thickness in
the affected patients (13). However, larger studies are needed to
reliably investigate group differences.
Bone Mineral Density and Microstructure
HR-pQCT provides 3D images, so volumetric bone mineral
density (vBMD, g/cm3) is assessed rather than areal BMD
(aBMD) that is reported by dual-energy x-ray absorptiometry
(DXA). Microstructural features of trabecular bone, including
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FIGURE 7 | Steps incorporated in the automated cortical interruption detection algorithm and measurement of underlying loss of trabecular bone, as visualized on a
2D grayscale image. (A) Detection of two cortical interruptions ≥0.41mm. (B) Region of interest (ROI) identified by dilating the cortical interruptions by 48 voxels
(corresponding to 3.936mm), and masking with the periosteal contour. (C) Only voids that are ≥0.738 in diameter are selected by performing a distance
transformation within the ROI. (D) Voids are eroded by 2 voxels to detach connections of ≤0.328mm and prevent leakage into the trabecular bone. (E) Inclusion of
voids that remain connected to a cortical interruption after erosion. (F) Dilation of voids to the original size, and inclusion of cortical interruptions that were originally
detected. Reproduced with permission from (53).
FIGURE 8 | Surface deformation model (61) showing: (Left) cross-section of MCP joint with the diseased surface (red) overlaid on the average healthy surface (blue).
(Right) 3D heat map representing distances between diseased (top) and healthy (bottom) surfaces. Positive distances reflect bony proliferations, while negative
distances represent erosive damage. Image provided courtesy of Worcester Polytechnic Institute (Kyle Murdock and Karen Troy).
trabecular thickness, number and separation, have been
measured directly and with greater accuracy using the second-
generation scanners compared to the first-generation scanner
(77). BMD and microstructure imaged by HR-pQCT have been
investigated in several different groups of patients and with focus
on different joints of interest as well as the typical measurements
of the distal radius and distal tibia applied in osteoporosis
studies. Most of these studies were cross-sectional, and the
majority of studies were done with either RA or PsA patients.
One study assessed the relationship of periarticular osteoporosis
in the wrist and MCP joint by HR-pQCT imaging with BMD in
axial skeletal sites by DXA. Areal BMD in the axial skeleton was
moderately correlated with vBMD assessed by HR-pQCT in both
the radius and 2nd metacarpal head while microarchitecture
only had a weak to moderate correlation in patients with RA
(8). Finally, one study investigated the correlation between bone
density and bone microstructure parameters measured at the
MCP joint and SvH score in patients with RA, but only found
a significant correlation between trabecular separation and SvH
score (3).
Six cross-sectional studies compared RA patients with healthy
subjects. Cortical and trabecular vBMD was significantly lower
in female and male patients with RA when compared to healthy
subjects at the distal radius, even though no difference in axial
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FIGURE 9 | Examples of osteophytes in the metacarpal head of PsA patients, which commonly show widespread involvement of the cortical bone. Images provided
courtesy of The Chinese University of Hong Kong (L-ST).
aBMD measured by DXA could be observed (17, 24). In the
same population, the cortical porosity and trabecular separation
were significantly greater, and bone volume fraction significantly
lower, in the RA patients (17, 19, 24). Volumetric BMD and
microarchitecture were similarly different at the MCP joints in
three of four studies. The trabecular vBMD, bone volume fraction
and thickness was significantly lower, while trabecular separation
was significantly higher in patients with RA compared to healthy
subjects (3, 12, 43, 45).
Five cross-sectional studies have investigated bone density
and microarchitecture in patients with PsA. At the radius,
cortical vBMD was significantly lower, while cortical porosity
was significantly higher in PsA patients compared to healthy
subjects. By DXA, the PsA patients had significantly higher
aBMD at the lumbar spine compared to healthy subjects; this
difference, however, became insignificant after adjusting for Body
Mass Index (BMI), suggesting BMI may have confounded the
relationship (4). Other studies have found a significant loss of
periarticular trabecular bone in PsA patients compared to healthy
subjects with regards to both vBMD (69) and bone structure
(27). Compared to treatment naïve PsA patients, patients with
a history of biological disease-modifying anti-rheumatic drugs
(DMARD) treatment had significantly higher vBMD, BV/TV as
well as greater trabecular number and thickness. No significant
differences in bone density or microarchitecture outcomes were
observed in patients previously treated with MTX compared to
treatment naïve PsA patients (68).
The trabecular number and vBMD were significantly lower,
while trabecular separation was significantly higher for PsA
patients when compared with RA patients. However, this
difference was only seen between ACPA positive RA patients
and PsA patients. The ACPA positive RA patients had a
significantly longer disease duration. Therefore, this difference
is more likely attributed to disease duration rather than the
underlying condition (20). In contrast, when comparing patients
with various chronic inflammatory diseases (ACPA-positive RA,
ACPA-negative RA, Crohn’s Disease, ulcerative colitis, psoriasis
and PsA) and healthy participants, vBMD differed only between
ACPA-positive RA and healthy subjects (56). Together these
findings suggest that to date, the bone density andmicrostructure
seems to be affected in different kinds of inflammatory
diseases, but the nature of these findings are unclear as the
periarticular bone density and microstructure are influenced by
other factors independent of the inflammatory nature of the
disease, such as genetic factors, sex, physical activity, height,
weight, BMI, smoking and alcohol consumption, and daily
calcium intake.
Reproducibility of the Pathological
Measures
Reproducibility has been reported for erosion measurements,
osteophytes, joint space width, bone mineral density and
microstructure (Table 2). Reproducibility is most often presented
as Intraclass correlation coefficients (ICC), root mean square
coefficient of variance (CVRMS%), but also as the coefficient
of variation. The reproducibility for bone mineral density,
microstructure, and most joint space width metrics are excellent
(Table 2). Reproducibility for erosion measures is generally
good but does show some variation. Due to the distinct
methods used for erosion quantification, these values are hard
to compare. Osteophyte assessment has the lowest values for
reproducibility (69).
When compared with reproducibility for semi-quantitative
scoring systems on MRI (RAMRIS) (78) and CR (SvH) (79),
HR-pQCT offers many advantages by using quantitative tools
for outcome measurement that require fewer operator inputs.
The reliability for erosion count was higher for HR-pQCT than
MRI. However, the ICC was excellent for both modalities (9, 28),
while only moderate for CR (55). The semi-automated or fully-
automated assessments of bone mineral density, microstructure,
joints space width and cortical interruptions result in intra-
reader and inter-reader differences that are non-existent, or
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FIGURE 10 | 3D volumetric joint space width analysis by HR-pQCT. (A) The relevant joint is identified; bone is segmented by thresholding, and bones are separated
based on their relevant position (distal and proximal). (B) Periosteal surfaces for each bone in the joint are identified using an automated process. (C) Joint space
volume is identified through a series of morphological operations and subtraction of the original bone volumes. (D) Joint space metrics are derived from the 3D map of
local joint space widths. The 3D map is shown in pseudo color (left), and as a distribution (right) for the 2nd metacarpal of an RA patient. Reproduced with permission
from (13).
nearly negligible because the analyses are automated, with the
exception of an allowance for corrections of bone segmentation.
Scan-rescan reproducibility for JSW minimum is similar to that
obtained with inter-reader ratings on 2D radiographs (RMSSD
0.18mm) but far superior for mean JSW (RMSSD 0.05mm)
(80). Intra- and inter-reader reproducibility and reliability for
erosion detection and volume are comparable to reproducibility
and reliability reported for the erosion domain of the RAMRIS
scoring system (9, 28, 81, 82).
Longitudinal Changes of the Pathological
Measures
While the diagnostic uses of HR-pQCT might be limited at
present, the research applications are vast. Several clinical trials
have been conducted using erosion volume by HR-pQCT as an
outcome measure. One of the major advantages is the potential
for shorter monitoring times to evaluate erosion progression
or repair. Fifteen studies have reported longitudinal changes in
the number and/or size of erosions. Of these, three investigated
PsA (14, 49, 66), 10 investigated patients with RA (6, 10, 15,
29, 42, 46, 58, 59, 64, 65), and one study examined ACPA+
individuals without arthritis (62). Seven studies investigated
intervention with different therapies either as an open-label study
or secondary analysis in a randomized controlled trial. Five of
the seven studies were done on patients with RA (12, 19, 43,
55, 69), and two in PsA (21, 60). In patients with established
RA, two studies of patients with mean disease duration more
than 5 years did not detect any change in erosions at 1-year
follow-up (10, 64). However, longitudinal changes are diverse.
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Studies which traced changes of individual erosions in patients
receiving care according to treat-to-target strategy over a 1-year
period have shown that 15–31% of erosions progress in size, 48–
65% were stable in size and 20–21% show partial repair after 1
year (29, 58, 67).
The shortest time interval over which significant changes
have been evaluated is 3 months. This study was conducted
enrolling patients with RA and a mean disease duration of
more than 5 years who were receiving either a TNF inhibitor
(TNFi) in combination with methotrexate or methotrexate alone.
While no significant changes in MRI outcome measures were
observed, a significant increase in erosion volume assessed by
HR-pQCT was observed for the methotrexate-treated patients,
and those on combination therapy with treatment response
had a demonstrated decrease in erosion volume (42). In this
same study, joint space did decrease significantly in patients
in combination therapy only. Paradoxically, this was not seen
in methotrexate-treated patients. However, methotrexate-treated
patients had smaller joint space at baseline, which may explained
why no change was seen after the 3-month follow-up (42).
Change in erosion volume after 3 and 6 months has also
been investigated for patients with RA and a mean disease
duration of roughly 10 years receiving either alendronate or
denosumab together with their regular DMARD treatment (46).
No significant change was observed after 3 months. Conversely,
erosion volume increased significantly in patients receiving
alendronate, while decreasing significantly in patients receiving
denosumab after 6 months. While these represent the shortest
time interval over which changes in erosion volume and JSW
have been observed, two studies have shown decreases in
erosion volume in response to tocilizumab in combination with
methotrexate for both patients with newly diagnosed RA (59)
and established RA (15); this has also been observed for patients
with established RA treated with TNFi in combination with
methotrexate (6) over a 1-year follow-up. Stabilization in erosion
size with therapy has also been demonstrated, in newly diagnosed
patients with RA on treatment with a TNFi in combination
with methotrexate (59). PsA studies have shown slower erosion
changes than RA; no significant progression in erosions was seen
in patients with established PsA after 24 weeks (49) or 1-year
(14). However, one study found progression of erosion number
and size after 5-years in patients with established PsA and a mean
disease duration of 14 years (66).
While the measurement of erosion size has been the most
commonly used outcome metric, osteophytes and bone quality
have also been assessed. Five longitudinal studies investigated
changes in osteophytes over time. In RA patients, no significant
change in osteophyte number or score was seen after a year (10).
However, an 18-month follow-up study did find an increase in
both osteophytes number and volume in RA patients in open-
label treatment (31). No change in osteophyte size was observed
in PsA patients treated with secukinumab for 24 weeks (49).
However, in patients treated with MTX and TNFi osteophyte
height increased over 1 year (14), and volume increased over 5
years in patients in open-label treatment (66).
Only six longitudinal studies of bone density and
microarchitecture in the MCP joint or the radius have been
reported. In longitudinal studies of RA or PsA patients without
a healthy control group, conducted with 3-month or 1-year
follow-up, no significant changes in vBMD or microstructure
were observed (42, 49, 58). In one study, greater decreases in
vBMD and microstructure over 1 year were observed in RA
patients compared to healthy controls (64), while two other
studies found comparable decreases in both early RA patients
and healthy controls (37, 62). Differences in disease duration,
treatment status, and the anatomic site measured may explain
the variable findings across studies. More extensive longitudinal
studies are needed to reveal the critical anatomic locations, time
course, and mechanisms of bone loss that should be strategically
targeted for observation.
Combined with advances in image processing and
image registration, individual spatially localized changes
can be monitored with high sensitivity and reliability
(Table 2) (64). To date, the published studies report
data for the joint region captured in the field of view,
and not for the local changes such as the peri-articular
region. Furthermore, these techniques can be applied
where only subtle changes are anticipated, such as
understanding bony damage progression in the presence of
subclinical inflammation.
Early Detection of Articular Damage in
Inflammatory Arthritis by HR-pQCT
Imaging
The sensitive detection of erosive damage and bony proliferation
suggests that HR-pQCT may have utility in the early detection
of articular damage in inflammatory arthritis. For conventional
radiographs, erosions have been observed to be prevalent in
∼50% of RA patients at clinical diagnosis, and up to 60% of
patients have erosions after 1 year (83). Therefore, the higher
sensitivity of HR-pQCT compared to conventional radiographs
is promising not only in assessing longitudinal changes but
may also be useful for early detection in patients where the
diagnosis is suspected but cannot be made clinically. However,
the ability to image multiple joints is limited by the acquisition
speed. Although many erosions occur in the standard scan
sites of the 2nd and 3rd metacarpals of the dominant hand,
other joints will be missed. Further, the contrast is insufficient
to detect inflammation (synovitis and osteitis, also referred to
as bone marrow oedema in RA patients) believed to be key
precursors to clinical disease. Nonetheless, two cross-sectional
studies found a significantly thinner trabecular bone in the MCP
joints of ACPA positive individuals with arthralgia compared
with ACPA negative healthy individuals (18, 50). Kleyer et al.
also observed significantly lower trabecular number, bone
volume fraction and vBMD in ACPA positive individuals with
arthralgia compared with ACPA negative healthy individuals
(18), suggesting that periarticular bone loss may be an early
sign of clinical disease. Changes to bone mineral density and
microstructure, however, is very non-specific to arthritis, as
possible changes can be attributed to many other factors.
Therefore, the use of bone mineral density and microstructure
for early detection of articular damage in inflammatory arthritis
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TABLE 2 | Reproducibility measures.
Author, year (ref) Participants Reproducibility feature Method Findings
Erosion count
Albrecht, 2013 (9) RA (n = 50) Inter-reader reliability Erosion count ICC range: metacarpal head: 0.936–1.00.
ICC range: phalangeal Base: 0.948–1.00.
Aschenberg, 2013 (10) RA (n = 40) Inter-reader reliability Erosion score ICC (range): 0.79 (0.57–0.95)
Hecht, 2015 (26) RA (n = 242) Inter-reader agreement Erosion count ICC: [0.87–1.00]
Regensburger, 2015
(28)
RA (n = 103) Inter-reader reliability Erosion count ICC [95% CI]: 0.98 [0.98–0.98]
Scharmga, 2016 (34) RA (n = 44); control (n = 38) Intra- and
inter-reader reliability
Cortical break count ICC [95% CI]: 0.61 [0.49–0.70] ICC [95%
CI]: 0.55 [0.43–0.65]
Peters, 2017 (40) RA (n = 32); control (n = 32) Inter-reader reliability Cortical break count
1>0.16mm,
2>0.33mm
3>0.53 mm
ICC [95% CI]: 0.91 [0.65–0.97]
ICC [95% CI]: 0.81 [0.52–0.92]
ICC [95% CI]: 0.52 [0.11–0.78]
Scharmga, 2017 (41) Cadaver (n = 7) Intra- and
inter-reader reliability
Cortical break count ICC range: 0.52–0.75
ICC range: 0.37–0.55
Peters, 2017 (39) RA (n = 7); control (n = 3) Inter-reader reliability Cortical break count ICC [95%CI]: 0.97 [0.90–0.99]
Peters, 2018 (53) eRA (n = 17);
undifferentiated arthritis (n
=4)
Inter-reader reliability
and reproducibility
Cortical interruptions count ICC [95%CI]: 0.96[0.89–0.97]
ICC [95%CI]: 0.94[0.89–0.97]
ICC [95%CI]: 0.96[0.92–0.98]
ICC [95%CI]: 0.94[0.89–0.97]
Scharmga, 2018 (54) RA (n = 39); control (n = 38) Intra- and
inter-reader reliability
Cortical interruptions ICC [95%CI]: 0.69[0.65–0.73]
ICC [95%CI]: 0.56[0.49–0.62]
Scharmga, 2018 (55) RA (n = 20); control (n = 10) Intra- and
inter-reader reliability
Cortical interruptions ICC [95%CI]: 0.88 [0.83–0.92]
ICC [95%CI]: 0.48 [0.20–0.67]
Simon, 2018 (57) PsA (n = 55); PsO (n = 55);
control (n = 47)
Inter-reader agreement Erosions number ICC: 0.96
Berlin, 2019 (60) Control (n = 120) Inter-reader agreement Erosion count ICC [95%CI]: 0.76 [0.62–0.86]
Erosion score
Aschenberg, 2013 (10) RA (n = 40) Inter-reader reliability Erosion and osteophyte
count and score
ICC (range): 0.79 (0.57–0.95)
Erosions width and depth
Finzel, 2013 (15) RA (n = 20) Intra- and
inter-reader reproducibility
Width and depth ICC: 0.99
ICC: 0.99
ICC: 0.93
ICC: 0.94
Lee, 2015 (1) RA (n = 16) Intra- and
inter-reader reproducibility
Sum maximum dimension. ICC: 0.89
ICC: 0.99
Barnabe, 2016 (30) Inter-reader reliability Width and depth CVRMS%: 12.3–20.6
CVRMS%: 22.2–24.0
Yue, 2017 (46) RA (n = 20); RA (n = 20) Intra- and
inter-reader reliability
Width and depth ICC [95%CI]: 0.99 [0.94–1.00]
ICC [95%CI]: 0.99 [0.96–1.00]
ICC [95%CI]: 0.98 [0.96–0.99]
ICC [95%CI]: 0.98 [0.97–0.99
Keller, 2017 (50) Control [ACPA+ (n = 29);
ACPA– (n = 29)]
Intrareader reproducibility Width and depth CV%: 14.9
CV%:10.8%
Ibrahim-Nasser, 2018
(48)
RA (n = 29) Inter-reader precision Width and depth CVRMS%: 16.0–20
CVRMS%: 17.5–23.4
Yue, 2018 (58) eRA (n = 63);
Remission/not remission
Intra- and
inter-reader reliability
Width and depth ICC [95%CI]: 0.97 [0.93–0.99]
ICC [95%CI]: 1.00 [0.99–1.00]
ICC [95%CI]: 0.98 [0.93–0.99]
ICC [95%CI]: 0.92 [0.70– 0.98]
Henchie, 2019 (61) RA (n = 17); PsA (n = 17);
control (n = 12)
Inter-reader precision Depth. RMSE: 4+/−3%
Precision error: 50µm
Erosion volume
Töpfer, 2014 (23) RA (n = 18) Inter-reader precision Volume (Half-ellipsoid).
Volume. (MIAF).
CVRMS%: 15.4
CVRMS%: 7.78
Regensburger, 2015
(28)
RA (n = 103) Inter-reader reliability Volume (Half-ellipsoid). ICC [95% CI]: 0.95 [0.94–0.96]
(Continued)
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TABLE 2 | Continued
Author, year (ref) Participants Reproducibility feature Method Findings
Töpfer, 2015 (29) RA (n = 22) Inter-reader precision Volume. (MIAF). CVRMS%: 6 – 8.3
Figueriredo, 2016 (31) ACPA+ RA (n = 202) Inter-reader reliability Volume (Half-ellipsoid). ICC [95%CI]: 0.96 [0.94–0.97]
Shimizu, 2017 (42) RA [(n = 27) TNFi/MTX n =
17/10)
Intra- and inter
reader agreement
Volume CVRMS%: 3.43
CVRMS%: 3.92
Yue, 2017 (46) RA (n = 20); RA (n = 20) Intra- and
inter-reader reliability
Volume ICC [95%CI]: 0.98 [0.87–1.00]
ICC [95%CI]: 0.96 [0.73–1.00]
Keller, 2017 (50) Control [ACPA+ (n = 29);
ACPA– (n = 29)]
Intrareader reproducibility Volume (Osirix) CV%20.6%,
Figueriredo, 2018 (47) RA (n = 65) Inter-reader reliability Volume (Half-ellipsoid)
Volume (MIAF)
Volume (mESE)
ICC [95%CI]: 0.95 [0.92–0.97]
ICC [95%CI]: 0.92 [0.79–0.97]
ICC [95%CI]: 0.99 [0.99–0.99]
Ibrahim-Nasser, 2018
(48)
RA (n = 29) Inter-reader precision error Volume (Osirix) CVRMS%: 16.0–20
CVRMS%: 17.5–23.4
CVRMS%: 14.0–21.2
Peters, 2018 (53) eRA (n = 17);
undifferentiated arthritis (n
=4)
Intra- Inter-reader reliability
and
Intra-
Inter-reader reproducibility
Cortical interruptions (CIDA) ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 0.91[0.81–0.96]
ICC [95%CI]: 1.00[0.99–1.00]
ICC [95%CI]: 0.91[0.81–0.96]
Simon, 2018 (57) PsA (n = 55); PsO (n = 55);
control (n = 47)
Inter-reader agreement Volume ICC: 0.90
Yue, 2018 (58) eRA (n = 63);
Remission/not remission
Intra- and
inter-reader reliability
Volume ICC [95%CI]: 0.95 [0.79–0.99]
ICC [95%CI]: 0.98 [0.83–1.00]
Shimizu, 2019 (65) RA [(n = 28) TNFi+/– n =
18/10]
Intra- and
Inter-reader reproducibility
Volume (Osirix) ICC: 0.93
ICC: 0.80
Wu, 2020 (69) PsA (n = 62); control (n =
62)
Inter-reader reliability Volume ICC [95%CI]: 1.00 [0.99–1.00]
Erosion surface area
Töpfer, 2014 (23) RA (n = 18) Inter-reader precision Surface Area (MIAF) CVRMS%: 9.89
Peters, 2017 (40) RA (n = 32); control (n = 32) Inter-reader reliability Cortical interruptions
1>0.16mm,
2>0.33mm
3>0.53 mm
1.ICC [95% CI]:0.93 [0.82–0.97
2.ICC [95% CI]:0.86 [0.67–0.94]
3.ICC [95% CI]:0.21 [−0.15–0.56]
Peters, 2017 (39) RA (n = 7); control (n = 3) Inter-reader reliability Cortical break Surface area ICC [95%CI]: 0.98 [0.92–1.00]
Peters, 2018 (53) eRA (n = 17);
undifferentiated arthritis (n
=4)
Intra-
Inter-reader reliability and
Intra-
Inter-reader reproducibility
Cortical interruptions
surface area (CIDA)
ICC [95%CI]: 0.95[0.92–0.98]
ICC [95%CI]: 0.70[0.41–0.84]
ICC [95%CI]: 0.95[0.92–0.98]
ICC [95%CI]: 0.70[0.41–0.86]
Erosion sphericity
Töpfer, 2014 (23) RA (n = 18) Inter-reader precision Sphericity. (MIAF). CVRMS%: 5.46
Erosion marginal osteosclerosis
Yue, 2017 (46) RA (n = 20); RA (n = 20) Intra- and
inter-reader reliability
Marginal osteosclerosis ICC [95%CI]: 0.98 [0.96–0.99]
ICC [95%CI]: 0.97 [0.90–0.99]
Yue, 2018 (58) eRA (n = 63);
Remission/not remission
Intra- and
inter-reader reliability
Marginal osteosclerosis ICC [95%CI]: 0.99 [0.91–1.00]
ICC [95%CI]: 0.94 [0.73–0.99]
Osteophyte count
Aschenberg, 2013 (10) RA (n = 40) Inter-reader reliability Count ICC (range): 0.79 (0.57–0.95)
Finzel, 2013 (21) PsA (n = 25); HOA (n = 25);
control (n = 20)
Intra-
Inter-reader reproducibility
Count Spearman’s rho (0.95–1.00) ICC 0.91
Simon, 2018 (57) PsA (n = 55); PsO (n = 55);
control (n = 47)
Inter-reader agreement Count ICC: 0.95
Berlin, 2019 (60) Control (n = 120) Inter-reader agreement Count ICC [95%CI]: 0.96 [0.92–0.98]
Osteophyte score
Aschenberg, 2013 (10) RA (n = 40) Inter-reader agreement Score ICC (range): 0.79 (0.57–0.95)
Finzel, 2013 (21) PsA (n = 25); HOA (n = 25);
control (n = 20)
Intra- and
Inter-reader reproducibility
Score Spearman’s rho (0.95–1.00) ICC 0.92
(Continued)
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TABLE 2 | Continued
Author, year(ref) Participants Reproducibility feature Method Findings
Osteophyte height
Finzel, 2013 (14) PsA [(n = 41) TNFi/MTX n =
28/13]; RA (n = 43)
Inter-reader reproducibility
Intra-reader reliability
Height r = 0.9692
r = 0.9722
Finzel, 2013 (21) PsA (n = 25); HOA (n = 25);
control (n = 20)
Inter-reader reproducibility Height
ICC 0.96
Simon, 2018 (57) PsA (n = 55); PsO (n = 55);
control (n = 47)
Inter-reader agreement Height ICC: 0.94
Henchie, 2019 (61) RA (n = 17); PsA (n = 17);
control (n = 12)
Inter-reader precision Periosteal bone
growth height
RMSE: 20+/−13%
Precision error:210µm
Wu, 2020 (69) PsA (n = 62); control (n =
62)
Inter-reader reliability Entesophyte height ICC [95%CI]: 0.74 [0.42–0.89]
Osteophyte volume
Wu, 2020 (69) PsA (n = 62); control (n =
62)
Inter-reader reliability Entesophyte volume ICC [95%CI]: 0.99 [0.97–0.99]
Bone mineral density
Fouque-Aubert, 2010
(3)
RA (n = 14); control (n = 14) Repositioning
and scan/rescan
BMD CV%: ≤ 1.8
Barnabe, 2013 (12) RA (n = 15); control (n = 15) Intrareader reproducibility BMD CVRMS%: < 0.83
Keller, 2017 (50) Control [ACPA+ (n = 29);
ACPA– (n = 29)]
Intrareader reproducibility BMD CV%: 0.6–3.53
Peters, 2018 (53) eRA (n = 17);
undifferentiated arthritis (n =
4)
Inter-reader reliability and
Intra-
Inter-reader reproducibility
BMD ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 1.00[1.00–1.00]
Wu, 2020 (69) PsA (n = 62); control (n =
62)
Inter-reader reliability BMD CV%: 0.38–1.03
Bone microstructure
Fouque-Aubert, 2010
(3)
RA (n = 14); control (n = 14) Repositioning
and scan/rescan
Microstructure CV%: ≤ 12.5
Barnabe, 2013 (12) RA (n = 15); control (n = 15) Intrareader reproducibility Microstructure CVRMS%: < 0.83
Keller, 2017 (50) Control [ACPA+ (n = 29);
ACPA– (n = 29)]
Intrareader reproducibility Microstructure CV%: 0.6–3.53
Peters, 2018 (53) eRA (n = 17);
undifferentiated arthritis (n
=4)
Inter-reader reliability and
Intra- and
inter-reader reproducibility
Microstructure ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 0.99[0.99–1.00]
ICC [95%CI]: 1.00[1.00–1.00]
ICC [95%CI]: 1.00[1.00–1.00]
Wu, 2020 (69) PsA (n = 62); control (n =
62)
Inter-reader reliability Microstructure CV%: 0.38–1.03
Joint space
Barnabe, 2013 (12) RA (n = 15); control (n = 15) Intrareader JSW CVRMS%: 17.1
Burghardt, 2013 (13) RA (n = 16); control (n = 7) Repositioning
and scan/rescan
JSV
JSW
JSW.SD
JSW.Min
JSW.MAX
JSW.AS
CVRMS%: 3.5
CVRMS%: 2.1
CVRMS%: 10.4
CVRMS%: 12.5
CVRMS%: 2.2
CVRMS%: 13.9
Tom, 2016 (36) Cadaver (n = 7) Repositioning
and scan/rescan
JSV
JSW
JSW.Min
JSW.Max
CVRMS%: 2.2
CVRMS%: 3.8
CVRMS%: 8.0
CVRMS%: 4.4
Stok, 2020 (70) RA (n = 30) Repositioning
and scan/rescan
JSV
JSW
JSW.Minimum
JSW.Maximum
JSW.Asymmetry
ICC [95%CI]: 0.99 [0.98–0.99]
ICC [95%CI]: 0.95 [0.91–0.97]
ICC [95%CI]: 0.66 [0.36–0.82]
ICC [95%CI]: 0.73 [0.50–0.86]
ICC [95%CI]: 0.75 [0.54–0.87]
ACPA, Anti-citrullinated protein antibodies; BMD, Bone mineral density; CV, coefficient of variance; CIDA, Cortical interruption detection algorithm; eRA, Early Rheumatoid arthritis; ICC,
Intra-class correlation coefficient; JSW, Joint space width; JSV, Joint space volume; MTX, Methotrexate; MIAF-finger, Medical Image Analysis Framework – Finger; mESE, modified
Evaluation Script for Erosions; PsO, Psoriasis; PsA, Psoriatic arthritis; RA, Rheumatoid arthritis; RMSE, root-mean-square error; CVRMS%, root mean square coefficient of variance;
TNFi, Tumor necrosis factor inhibitors.
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is still limited. The number and volume of erosions have been
shown to increase over a 1-year period in ACPA positive
individuals with arthralgia but with no sign of arthritis and when
compared with an ACPA negative control group (62). Therefore,
erosion number and size may be a sensitive measure for early
RA progression.
CURRENT LIMITATIONS AND FUTURE
DIRECTIONS FOR IMPROVEMENT
Availability of an Accessible Tool for
Erosion Quantification
Clinical studies have been successfully performed using HR-
pQCT and a variety of custom software packages for analysis.
The detection of clinical erosive features is demonstrated, as
well as the reproducibility and sensitivity to measure change.
However, while erosion volume quantification shows clear
promise as an outcome measure, one of the challenges has
been the heterogeneity of approaches to identify erosions and
measure their size. This also includes distinguishing erosions
from other physiological features. An ideal tool would require
minimal operator input but allow corrections when necessary.
Furthermore, current approaches have been built with a variety
of proprietary and/or custom software packages which are
typically only accessible to individual research groups. To
improve reproducibility and consistency of definitions, as well as
the widespread adoption of semi-automated techniques, a new
approach must be developed in an open-source, user-friendly
software platform. Machine learning approaches may also better
automate erosion detection (84).
Segmentation to Assess the Cortical and
Trabecular Bone Density and
Microstructure
The current standard approach for segmentation to assess bone
mineral density and microstructure is a semi-automated slice-
by-slice hand contouring approach or semi-automated edge
detection algorithm (85). The algorithms were developed for
the distal radius and tibia with the assumption that cortical
bone is thicker and denser than trabecular bone, which is not
necessarily appropriate for the MCP and PIP joints (86). As
well, joints with low bone mineral density and high cortical
porosity, such as seen in advanced RA, have proven problematic
for the algorithms. The presence of cortical breaks and erosions
is also problematic for the existing segmentation approaches,
i.e., there exists no consensus as to whether the site of an
erosion should be included or excluded. Another important
consideration for the examined joint is how much of the bone
should be segmented, some have used a volume of interest that
spans the majority of the metaphysis, and is standardized to be
10% of the metacarpal length (45). However, presently, there is
no consensus on this matter.
To date, significant differences in bone mineral density and
microstructure between patients with inflammatory arthritis
and healthy controls were primarily reported for the trabecular
bone compartment. It is possible that further development
of the segmentation algorithms and the imaging resolution
could improve segmentation accuracy and might reveal greater
differences in the cortical bone of inflammatory arthritis patients.
Motion Compensation
One disadvantage of HR-pQCT imaging is that the lengthy,
but highly sensitive acquisition process renders it susceptible to
motion artifacts, which can impair the ability to accurately and
precisely quantify bone and joint outcomes (87, 88). To date, the
number of scans excluded for patient motion is rarely reported
with sufficient detail, and as such, it is challenging to know the
impact of motion on outcomes.
Motion artifact is particularly problematic for longitudinal
studies or when implementing more advanced analyses, such
as quantifying bone structure, formation, and resorption (89,
90). While this technique holds promise to identify erosions
undergoing repair or progression (64), the technique is currently
limited to cross-sectional studies because motion artifact
typically occurs in the multi-acquisition scan (multi-stack) for
joints, and might falsely detect repair or progression. A partial
solution to this problem has been implemented by overlapping
the acquisitions. However, this simply serves to smooth the
effects of motion on scan quality rather than eliminate it
(90). Ideally, existing motion compensation algorithms could
be implemented in HR-pQCT image reconstruction software
to reduce data loss and maximize the utility of acquired data
(91, 92).
Joints of Interest
Conventional radiographs assess erosions in 16 joints in each
hand and six joints in each foot. Presently, the image acquisition
protocol recommended by the SPECTRA Collaboration for the
MCP joints specifies that at a minimum, both the 2nd and 3rd
MCP should be imaged (93). There is currently no standard
image acquisition protocol for the PIP joints. In spite of this, a
limited number of published studies have investigated the PIP
joint in a similar fashion as the MCP joints (12, 34, 49, 52,
54, 55, 60, 64). The wrist is also examined in multiple studies
with the intention of evaluation of bone mineral density and
microstructure of the radius, and JSW in the wrist (13). Still, no
protocol for assessing erosions in the radius have been published.
Whether there is any benefit to include other joints such as the
knee, elbow, ankle or foot remains unclear, but are accessible for
HR-pQCT imaging. For the HR-pQCT to be a viable modality
for assessing progression in clinical practice, further research to
explicitly investigate the number and which specific joints needed
for the HR-pQCT scanner to have an added benefit compared to
CR are needed.
Disadvantages of HR-pQCT Scanning and
the Limited Field of View
TheHR-pQCT scanner is not widely available tomost researchers
or clinicians. Presently, HR-pQCT scanners are only developed
by Scanco Medical (Bruttisellen, Switzerland). Worldwide only
93 HR-pQCT scanners are installed (46 of the first-generation
and 47 of the second-generation), and about 20 research groups
use the technology in rheumatological research, this limits the
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feasibility of implementing the method in clinical practice at this
time. However, the existing HR-pQCT models use cone-beam
configurations (conical x-ray beam which projects onto a flat
panel detector), the term “cone-beam CT” has been adopted in
reference to scanners with a very large detector that commonly
uses this hardware configuration. Cone-beamCT provides higher
spatial resolution at lower costs than conventional multi-detector
CT systems (94). Acquisition times can be much faster (<1min
vs. 6 to 9min) than HR-pQCT due to the larger detector sizes.
Improvements to image reconstruction can advance the accuracy
of bone microarchitectural measurement to be comparable with
HR-pQCT (95, 96). Therefore, cone-beam CT could be a viable
modality to complement HR-pQCT imaging, thereby increasing
access. The outcome measures described throughout this review
could be widely implemented for cone-beam CT. Another
limitation of exclusively using HR-pQCT for inflammatory
arthritis is the inability to visualize soft tissue and inflammation.
Dual-energy CT scans acquire projections at two different energy
levels to take advantage of differing attenuation coefficients
for different tissues at each energy (97–99). Approaches have
been implemented in commercial multi-detector CT scanners
(100) and have been used to identify tophi and other crystal
arthropathies (101–103), as well as more recently to identify
bone marrow edema (104, 105). While not currently available in
HR-pQCT scanners, there is the potential that future extremity
CT scanners will additionally be able to quantify soft tissue and
inflammatory abnormalities.
Using Multi-Modal Imaging to Link Erosive
Damage to Inflammatory Markers
Investigators have proceededwith evaluating if HR-pQCT images
and findings can be used in conjunction with those obtained
using US or MRI to provide a comprehensive overview of soft
tissue and bone in the same joint. A complimentary paper on
this topic is included in this issue (Tse et al., submitted). In
particular, the presence of hyperintense signals on MRI linked
to inflammation in RA patients, such as osteitis (106) and
synovitis is associated with more pronounced erosive damage
in patients with RA (52, 54). In the radius of patients with RA,
bone mineral density, trabecular thickness and number were
significantly higher, while trabecular separation was lower in
regions with MRI-defined osteitis than without (22). Similarly,
USDoppler-positive RA patients identified with ultrasound had a
lower trabecular number and vBMD alongside higher trabecular
separation and distribution of trabecular separation in the MCP
joints compared to Doppler negative patients (51).
Education for Patients and Students
Lastly, the use of HR-pQCT imaging as possible pedagogical
tool should not be overlooked. The spatial and high-resolution
imaging are useful for developing 3D models of the periarticular
changes of the joint. 3D printed prototypes of arthritic and
healthy joints from HR-pQCT data have been investigated as
a tool to demonstrate joint disease to address an eventual gap
in patient education and disease understanding (38). The HR-
pQCT data have also been used with Virtual Reality application
for student training (107).
CONCLUSIONS
In conclusion, owing to the ability to detect change over
time periods as short as 3 months, there is a great capacity
to utilize HR-pQCT measurements as outcomes in future
clinical trials. In addition, HR-pQCT provides uniquely high
in-vivo sensitivity for erosion detection compared to other
modalities. The erosion measures, joint space narrowing,
bone density and microstructure have high to excellent
reproducibility, whereas osteophytes measure only showed
moderate to high reproducibility. The highly sensitive assessment
of bone microstructure and damage has the potential to
better understand bone changes, particularly in the early stages
of inflammatory diseases. Finally, new research developments
will improve the accessibility of scanners, the field of view
of the imaging, analysis tools such as automatic methods
for longitudinally evaluating distinct erosions, as well as the
versatility for measuring tissues other than only bone.
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